Tenoliof (Tenoxicam) lyophilisate for solution preparation
22032USD

Tenoliof (Tenoxicam) lyophilisate for solution preparation

SKU:2410
To favorites
Tenoliof (Tenoxicam) lyophilisate for solution preparation non-steroidal anti-inflammatory drug (NSAID), in addition to anti-inflammatory, analgesic and antipyretic action, the drug also prevents platelet aggregation
Active substance:Tenoxicam
Pharmacological group:Lyophilisate
Formulation:SOLUTION
Country of origin:Romania
In stock
$20
11
Description
Features
Reviews

Instructions for Tenoliof (Tenoxicam) lyophilisate for solution preparation

English product name Tenoliof
Tenoliof

Release Form Tenoliof
lyophilizate d/prescription r-ra d/v/v and b/m of introduction 20 mg: fl. 1 or 3 pcs. per set with solvent

Description lyophilisate for solution preparation:

Lyophilizate for preparation of solution for injection into/into/into/into/out - lyophilized powder or compacted mass from yellow to greenish-yellow; solvent - colorless transparent liquid.

1 fl
tenoxicam 20 mg
Auxiliary substances: mannitol - 66 mg, sodium disulpite - 2.1 mg, dehydrate edetate - 0.22 mg, tromethamol - 3.4 mg, sodium hydroxide solution 1M - up to pH 9.8±0.2.

Solvent composition (per 1 amp.): water d/i - 2 ml.

20 mg - bottles (1) with a distributor (amp). 2 ml-1 pcs.) - packages of cell contours (1) - packs of cardboard.
20 mg - bottles (3) with a distributor (amp). 2 ml-3 pcs.) - packages of cell contours (1) - packs of cardboard.

ATC codes
M01AC02 Tenoxicam

Active substance
tenoxicam

Pharmaco-therapeutic group Tenoliof

NSAIDs

Pharmacological effect Tenoxicam

NSAIDs of the Oxicam class. It has a powerful analgesic and anti-inflammatory effect, the antipyretic effect is less pronounced. The mechanism of action is based on the suppression of the activity of the isoenzymes COX-1 and COX-2, as a result of which prostaglandin synthesis in the site of inflammation, as well as in other tissues of the body, is reduced. In addition, tenoxicam reduces the accumulation of leukocytes in the site of inflammation. A distinctive feature of tenoxicam is its long duration of action. Its T1/2 is 72 h.

Testimony Tenoliof

Symptomatic treatment as an anti-inflammatory and analgesic agent: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, articular syndrome in aggravation of gout, bursitis, tendovaginitis; pain syndrome of mild and moderate intensity (artralgia, myalgia, neuralgia, migraine, toothache and headache, algodismenorrhea); pain in injuries, burns. Inflammatory and degenerative diseases of the musculoskeletal system, accompanied by pain syndrome, such as sciatica, lumbago, epicondylitis.

Method of use, course and dosage Tenoxicam

Used inwards, in/in, in/m. The recommended dose is twenty mg once a day. The duration of treatment is 7-14 days.

  • Nosology Tenoxicam (ICD codes)
  • G43
  • Migraine
  • K08.8
  • Other refined changes of teeth and their support apparatus (including toothache)
  • M05
  • Seropositive rheumatoid arthritis
  • M10
  • Podagra
  • M13.9
  • Arthritis unspecified
  • M15
  • Polyarthrosis
  • M19.9
  • Arthrosis unspecified
  • M25.5
  • Joint pain
  • M42
  • Spinal osteochondrosis
  • M45
  • Ankylosing spondylitis
  • M47
  • Spondylosis
  • M54.1
  • Radikulopathy
  • M54.3
  • Ishias
  • M54.4
  • Lumbago with Sciatica
  • M65
  • Synovitis and tenosinovites
  • M70
  • Soft tissue diseases related to load, overload and pressure
  • M71
  • Other bursopathy
  • M77
  • Other Entesopathy (epicondylitis)
  • M79.1
  • Mialgia
  • M79.2
  • Neuralgia and Neuritis Unspecified
  • N94.4
  • Primary Dysmenorrhea
  • N94.5
  • Secondary dysmenorrhea
  • R51
  • Headache
  • R52.0
  • Acute pain
  • R52.2
  • Other persistent pain (chronic)
  • T14.0
  • Superficial injury of an unspecified area of the body (including abrasion, bruising, bruising, hematoma, bite of a non-venomous insect)
  • T14.3
  • Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint
  • T14.9
  • Injury unspecified
  • T30
  • Thermal and chemical burns of unspecified location
Features
Active substance
Pharmacological group
Formulation
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Analogues
Artoxan (Tenoxicam) 20 mg 3 ampoules
SKU:1867
$28
In stock